RAFFA WEALTH MANAGEMENT, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1631073
WASHINGTON, DC
Position in ALNY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,321
+$35 QoQ
Shares Held
21
+10.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#188
of 228 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RAFFA WEALTH MANAGEMENT, LLC holds $112,928 across 35 Biotechnology names. ALNY ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66 | $32,784 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $15,588 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
46 | $8,614 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
60 | $7,354 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
191 | $6,759 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
21 | $6,321 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | MRNA |
Moderna, Inc.
|
63 | $4,411 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,321 | 21 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,286 | 19 | Shares | Sole | 2026-07-27 | |
| 2025-12-31 | $7,157 | 18 | Shares | Sole | 2026-07-27 | |
| 2025-09-30 | $6,840 | 15 | Shares | Sole | 2026-07-27 | |
| 2025-06-30 | $4,239 | 13 | Shares | Sole | 2026-07-27 | |
| 2025-03-31 | $3,510 | 13 | Shares | Sole | 2026-07-27 | |
| 2024-12-31 | $3,059 | 13 | Shares | Sole | 2026-07-27 | |
| 2024-09-30 | $3,575 | 13 | Shares | Sole | 2026-07-27 | |
| 2024-06-30 | $3,159 | 13 | Shares | Sole | 2026-07-27 | |
| 2024-03-31 | $1,942 | 13 | Shares | Sole | 2026-07-27 | |
| 2023-12-31 | $2,488 | 13 | Shares | Sole | 2026-07-27 | |
| 2023-09-30 | $2,302 | 13 | Shares | Sole | 2026-07-27 | |
| 2023-06-30 | $2,469 | 13 | Shares | Sole | 2026-07-27 | |
| 2023-03-31 | $2,604 | 13 | Shares | Sole | 2026-07-27 | |
| 2022-12-31 | $3,089 | 13 | Shares | Sole | 2026-07-27 | |
| 2022-09-30 | $3,803 | 19 | Shares | Sole | 2026-07-27 | |
| 2022-06-30 | $1,896 | 13 | Shares | Sole | 2026-07-27 | |
| 2022-03-31 | $2,122 | 13 | Shares | Sole | 2026-07-27 | |
| 2021-12-31 | $2,204 | 13 | Shares | Sole | 2026-07-27 | |
| 2021-09-30 | $2,454 | 13 | Shares | Sole | 2026-07-27 | |
| 2021-06-30 | $2,203 | 13 | Shares | Sole | 2026-07-27 | |
| 2021-03-31 | $3,812 | 27 | Shares | Sole | 2026-07-27 | |
| 2020-12-31 | $2,599 | 20 | Shares | Sole | 2026-07-27 | |
| 2020-09-30 | $3,931 | 27 | Shares | Sole | 2026-07-27 | |
| 2020-06-30 | $3,702 | 25 | Shares | Sole | 2026-07-27 | |
| 2020-03-31 | $2,721 | 25 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||